Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Diabetes & Metabolism

• Publication date

  2012-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.diabet.2011.11.003PMID 22209680
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Events: A Meta-Analysis of Randomized Clinical Trials

  2011cited by this paper
• Weight-Related Quality of Life, Health Utility, Psychological Well-Being, and Satisfaction With Exenatide Once Weekly Compared With Sitagliptin or Pioglitazone After 26 Weeks of Treatment

  2011cited by this paper
• Diabetes and Employment

  2011cited by this paper
• Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study.

  2011influential reference
• Transition From Intravenous to Subcutaneous Insulin

  2011cited by this paper
• Standards of Medical Care in Diabetes—2011

  2011cited by this paper
• What would be the outcome if the American Diabetes Association recommendations of 2010 had been followed in our pratice in 1998–2006?

  2011cited by this paper
• High‐density lipoprotein‐cholesterol and not HbA1c was directly related to cardiovascular outcome in PROactive

  2011cited by this paper
• Cardiovascular safety of liraglutide assessed in a patient-level pooled analysis of phase 2—3 liraglutide clinical development studies

  2011cited by this paper
• Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin–Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study

  2011cited by this paper
• A1C Versus Glucose Testing: A Comparison

  2011cited by this paper
• Continuous glucose monitoring reveals different glycemic responses of moderate- vs high-carbohydrate lunch meals in people with type 2 diabetes.

  2010cited by this paper
• Metformin use and mortality among patients with diabetes and atherothrombosis.

  2010cited by this paper
• Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation

  2010cited by this paper
• Assessing the cardio–cerebrovascular safety of vildagliptin: meta‐analysis of adjudicated events from a large Phase III type 2 diabetes population

  2010cited by this paper
• Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies

  2010cited by this paper
• A European Evidence-Based Guideline for the Prevention of Type 2 Diabetes

  2010cited by this paper
• Dipeptydil peptidase-4 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials.

  2010cited by this paper
• Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study

  2010cited by this paper
• A Systematic Assessment of Cardiovascular Outcomes in the Saxagliptin Drug Development Program for Type 2 Diabetes

  2010cited by this paper
• Ill Adults: A Meta-analysis Benefits and Risks of Tight Glucose Control in Critically

  2010cited by this paper
• Effect of nateglinide on the incidence of diabetes and cardiovascular events.

  2010cited by this paper
• Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes

  2010cited by this paper
• Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction.

  2010cited by this paper
• Intensive versus conventional glucose control in critically ill patients.

  2009influential reference
• Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database

  2009cited by this paper
• American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control

  2009cited by this paper
• Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: a population‐based follow‐up study

  2009cited by this paper
• Consensus statement on self-monitoring of blood glucose in diabetes: A European perspective

  2009cited by this paper
• A1C and Diabetes Diagnosis: The Rancho Bernardo Study

  2009cited by this paper
• A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study

  2009cited by this paper
• Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients

  2009influential reference
• Implementation of standardized instructions for insulin at hospital discharge.

  2009cited by this paper
• Effect of second-generation sulfonylureas on survival in patients with diabetes mellitus after myocardial infarction.

  2009cited by this paper
• International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes

  2009cited by this paper
• Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction.

  2009cited by this paper
• Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).

  2009cited by this paper
• Effect of carbohydrate distribution on postprandial glucose peaks with the use of continuous glucose monitoring in type 2 diabetes.

  2008cited by this paper
• Oral Glucose Tolerance Test: A Reliable Tool for Early Detection of Glucose Abnormalities in Patients With Acute Myocardial Infarction in Clinical Practice

  2008cited by this paper
• Glucometrics in Patients Hospitalized With Acute Myocardial Infarction: Defining the Optimal Outcomes-Based Measure of Risk

  2008cited by this paper
• Intensive insulin therapy and pentastarch resuscitation in severe sepsis.

  2008cited by this paper
• Cardiovascular outcomes in trials of oral diabetes medications: a systematic review.

  2008cited by this paper
• Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism.

  2008cited by this paper
• The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study.

  2008cited by this paper
• Metformin: Effects on Micro and Macrovascular Complications in Type 2 Diabetes

  2008cited by this paper
• Review of an article: The ADVANCE Collaborative Group. (2008). Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. NEJM 2008;358:2560-2572.

  2008cited by this paper
• Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

  2008cited by this paper
• Benefits and risks of tight glucose control in critically ill adults: a meta-analysis.

  2008cited by this paper
• Optimizing the therapeutic benefits of exercise in Type 2 diabetes.

  2007cited by this paper
• Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.

  2007cited by this paper
• The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.

  2007cited by this paper
• Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review

  2007cited by this paper
• Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists.

  2007cited by this paper
• Impact of fasting glycemia on short-term prognosis after acute myocardial infarction.

  2007influential reference
• Are sulphonylureas all the same? A cohort study on cardiovascular and cancer‐related mortality

  2007cited by this paper
• Early impact of insulin treatment on mortality for hyperglycaemic patients without known diabetes who present with an acute coronary syndrome

  2007cited by this paper
• Intensive Insulin Therapy in Critical Care

  2007cited by this paper
• The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study.

  2007cited by this paper
• Is admission hyperglycaemia in non-diabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance?

  2006influential reference
• Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units

  2006cited by this paper
• Effects of mitiglinide and sulfonylureas in isolated canine coronary arteries and perfused rat hearts.

  2006cited by this paper
• The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction.

  2006influential reference
• Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart

  2006cited by this paper
• Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women.

  2006cited by this paper
• Exercise for type 2 diabetes mellitus.

  2006cited by this paper
• Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study.

  2005cited by this paper
• Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy.

  2005cited by this paper
• Frequency of undiagnosed diabetes mellitus in patients with acute coronary syndrome.

  2005cited by this paper
• Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial Infarction: Implications for Patients With and Without Recognized Diabetes

  2005cited by this paper
• Make your diabetic patients walk: long-term impact of different amounts of physical activity on type 2 diabetes.

  2005cited by this paper
• Repetitive postprandial hyperglycemia increases cardiac ischemia/reperfusion injury: prevention by the α‐glucosidase inhibitor acarbose

  2005cited by this paper
• Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.

  2005cited by this paper
• Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury.

  2005cited by this paper
• Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

  2005cited by this paper
• Effects of a low-fat diet compared with those of a high-monounsaturated fat diet on body weight, plasma lipids and lipoproteins, and glycemic control in type 2 diabetes.

  2004cited by this paper
• The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart.

  2004cited by this paper
• Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events.

  2004cited by this paper
• Including walnuts in a low-fat/modified-fat diet improves HDL cholesterol-to-total cholesterol ratios in patients with type 2 diabetes.

  2004cited by this paper
• Abnormal glucose tolerance – a common risk factor in patients with acute myocardial infarction in comparison with population‐based controls

  2004cited by this paper
• Effects of Glucagon-Like Peptide-1 in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction After Successful Reperfusion

  2004cited by this paper
• Recommandations SFC/ALFEDIAM sur la prise en charge du patient diabétique vu par le cardiologue

  2004cited by this paper
• [SFC/ALFEDIAM (French Cardiology Society/French-speaking Association for the Study of Diabetes and Metabolic Diseases) guidelines on the management of the diabetic patient seen by a cardiologist. Recommendations, rationale, references].

  2004cited by this paper
• Effects of cardiac rehabilitation on exercise capacity in Type 2 diabetic patients with coronary artery disease

  2004cited by this paper
• Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies.

  2004cited by this paper
• The Incidence and Severity of Adverse Events Affecting Patients after Discharge from the Hospital

  2003cited by this paper
• Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.

  2003cited by this paper
• Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?

  2003cited by this paper
• Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes.

  2003cited by this paper
• Exercise capacity and mortality among men referred for exercise testing.

  2002cited by this paper
• Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study.

  2002influential reference
• Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)

  2001cited by this paper
• Clinical and cost outcomes of medical nutrition therapy for hypercholesterolemia: a controlled trial.

  2001cited by this paper
• Windows of opportunity to improve diabetes care when patients with diabetes are hospitalized for other conditions.

  2001cited by this paper
• Exercise-based rehabilitation for coronary heart disease.

  2001cited by this paper
• Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.

  2001cited by this paper
• Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide)

  2000cited by this paper
• Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction.

  1999cited by this paper
• The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.

  1999cited by this paper
• A dietitian-delivered group nutrition program leads to reductions in dietary fat, serum cholesterol, and body weight: the Worcester Area Trial for Counseling in Hyperlipidemia (WATCH).

  1999cited by this paper
• Effect of physician specialty on outcomes in diabetic ketoacidosis.

  1999cited by this paper

• Evidence of a bi-directional relationship between heart failure and diabetes: a strategy for the detection of glucose abnormalities and diabetes prevention in patients with heart failure

  2024cites this paper
• [Acute coronary syndromes in diabetes mellitus : A comparative study between diabetics and non-diabetics patients in Senegalese urban environment].

  2024cites this paper
• Editorial: Hyperglycemia and Coronary Artery Diseases: Physio-Pathological Findings and Therapeutic Implications

  2022cites this paper
• Prediabetes and insulin resistance in a population of patients with heart failure and reduced or preserved ejection fraction but without diabetes, overweight or hypertension

  2022cites this paper
• The Impact of Hypoglycemic Therapy on the Prognosis for Acute Coronary Syndrome in Patients with Type 2 Diabetes

  2022cites this paper
• Basic types of the first-day glycemia in acute myocardial infarction: Prognostic, diagnostic, threshold and target glycemia.

  2021cites this paper
• Stress-Induced Hyperglycaemia in Non-Diabetic Patients with Acute Coronary Syndrome: From Molecular Mechanisms to New Therapeutic Perspectives

  2021cites this paper
• Prognostic value of admission hyperglycaemia in black Africans with acute coronary syndromes: a cross-sectional study.

  2020cites this paper
• Prognostic values of fasting hyperglycaemia in non-diabetic patients with acute coronary syndrome: A prospective cohort study

  2020cites this paper
• Complications cardiovasculaires macro-angiopathiques et insuffisance cardiaque chez le diabétique

  2019cites this paper
• Glycaemic variability is associated with severity of coronary artery disease in patients with poorly controlled type 2 diabetes and acute myocardial infarction.

  2019cites this paper
• Response to Comment on Gerbaud et al. Glycemic Variability Is a Powerful Independent Predictive Factor of Midterm Major Adverse Cardiac Events in Patients With Diabetes With Acute Coronary Syndrome. Diabetes Care 2019;42:674–681

  2019cites this paper
• Comment on Gerbaud et al. Glycemic Variability Is a Powerful Independent Predictive Factor of Midterm Major Adverse Cardiac Events in Patients With Diabetes With Acute Coronary Syndrome. Diabetes Care 2019;42:674–681

  2019cites this paper
• Perioperative management of adult diabetic patients. Review of hyperglycaemia: definitions and pathophysiology.

  2018cites this paper
• Practical management of diabetes patients before, during and after surgery: A joint French diabetology and anaesthesiology position statement.

  2018cites this paper
• Detection of glucose metabolism disorders in coronary patients enrolled in cardiac rehabilitation: Is glycated haemoglobin useful? Data from the prospective REHABDIAB study

  2018cites this paper
• The Electronic Pharmaceutical Record: A new method for medication reconciliation

  2018cites this paper
• In-Hospital Implementation of Evidence-Based Medications is Associated with Improved Survival in Diabetic Patients with Acute Coronary Syndrome - Data from TSOC ACS-DM Registry.

  2018cites this paper
• High efficacy of screening for diabetes and prediabetes in cardiac rehabilitation after an acute coronary syndrome (ACS). The REHABDIAB study.

  2017cites this paper
• [Prediabetes, definition and treatment].

  2017cites this paper
• Insuffisance coronaire, cardiomyopathie et neuropathie autonome cardiovasculaire chez le diabétique : traitement

  2017cites this paper
• Long‐term mortality after acute myocardial infarction among individuals with and without diabetes: A systematic review and meta‐analysis of studies in the post‐reperfusion era

  2017cites this paper
• Alprostadil protects type 2 diabetes mellitus patients treated with metformin from contrast-induced nephropathy

  2017cites this paper
• Le pré-diabète, définition et prise en charge

  2017cites this paper
• Texte 1 : rappels sur l’hyperglycémie

  2017cites this paper
• Management of hyperglycemia during and in the immediate follow-up of acute coronary syndrome

  2017cites this paper
• Proposal of a New Approach to Study and Categorize Stress Hyperglycemia in Acute Myocardial Infarction.

  2016cites this paper
• Effectiveness, safety and feasibility of an evidence-based insulin infusion protocol targeting moderate glycaemic control in intensive cardiac care units

  2016cites this paper
• [Management of hyperglycemic/diabetic patient during and in the immediate follow-up of an acute coronary syndrome].

  2016cites this paper
• 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment

  2015cites this paper
• Cardiac damage associated with stress hyperglycaemia and acute coronary syndrome changes according to level of presenting blood glucose.

  2015cites this paper
• Various admission glucose cut-offs for prognostication and for therapeutic threshold in acute myocardial infarction.

  2015cites this paper
• High rate of abnormal glucose tolerance in Brazilian individuals undergoing coronary angiography.

  2015cites this paper
• A multicenter observational study on the management of hyperglycemia in patients with acute coronary syndrome.

  2015cites this paper
• [2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation].

  2015cites this paper
• Wytyczne ESC dotyczące postępowania w ostrych zespołach wieńcowych bez przetrwałego uniesienia odcinka ST w 2015 roku Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) do spraw postępowania w ostrych zespołach wieńcowych bez przetrwałego uniesienia odcinka ST

  2015cites this paper
• Individuals with prediabetes identified by HbA1c undergoing coronary angiography have worse cardiometabolic profile than those identified by fasting glucose

  2014cites this paper
• Le syndrome coronarien aigu des populations fragiles

  2014cites this paper
• Choosing an insulin regime: a developing country perspective

  2014cites this paper
• Characteristics of diabetic patients and diabetes care in cardiac rehabilitation.

  2014cites this paper
• Beneficial metabolic effects of insulin infusion may be jeopardized by volume overload.

  2014cites this paper
• Stress hyperglycemia in acute myocardial infarction.

  2014cites this paper
• Identification of Target Populations for Intervention

  2013cites this paper
• Platelet reactivity in diabetic patients undergoing coronary stenting for acute coronary syndrome treated with clopidogrel loading dose followed by prasugrel maintenance therapy.

  2013cites this paper
• Survey of diabetes care in patients presenting with acute coronary syndromes in Canada.

  2013cites this paper
• How to Manage Hyperglycemia in an Acute Coronary Syndrome Patient

  2013cites this paper
• Stress hyperglycemia in acute ST-segment elevation myocardial infarction is a marker of left ventricular remodeling

  2013cites this paper
• Critical appraisal of the 'Consensus statement on care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of an acute coronary syndrome'.

  2012cites this paper
• 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).

  2011cites this paper